
Dr. Mali's Top 5 Predictions in Ophthalmology for 2023
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
In this episode, I share my top five predictions for 2023 in the field of ophthalmology.
Brought to you by Alcon
- Welcome to another exciting episode of Eye Care insider :52
- My review of the top five predictions in ophthalmology 1:03
- Prediction #1 – Vabysmo and anti-VEGF market 1:53
- Prediction #2 – FDA approval for GA treatment 4:26
- Prediction #3 – SNAPS eye shield for ocular protection 6:06
- Prediction #4 – biosimilars and the ophthalmic therapeutic marketplace 10:08
- Prediction #5 – retina analytical tools 12:27
- Thanks for listening 14:30
We’d love to hear from you! Send your comments/questions to Dr. Mali at eyecareinsider@healio.com. Follow us on Twitter @Healio_OSN.
Disclosures: Mali reports he is founder and CEO of Mali Enterprises; retina medical director at Macular Degeneration Association; consultant/speaker for Genentech and Roche; equity owner for SNAPS; and grant/consultant for RetinAI.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.